ZA943036B - 1,4-disubstituted piperidine derivative compounds - Google Patents

1,4-disubstituted piperidine derivative compounds

Info

Publication number
ZA943036B
ZA943036B ZA943036A ZA943036A ZA943036B ZA 943036 B ZA943036 B ZA 943036B ZA 943036 A ZA943036 A ZA 943036A ZA 943036 A ZA943036 A ZA 943036A ZA 943036 B ZA943036 B ZA 943036B
Authority
ZA
South Africa
Prior art keywords
derivative compounds
piperidine derivative
disubstituted piperidine
disubstituted
compounds
Prior art date
Application number
ZA943036A
Inventor
Rafael Foguet
Jordi Bolos
Aurelio Sacristan
Jose A Ortiz
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of ZA943036B publication Critical patent/ZA943036B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA943036A 1993-05-18 1994-05-03 1,4-disubstituted piperidine derivative compounds ZA943036B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09301062A ES2066721B1 (en) 1993-05-18 1993-05-18 NEW COMPOUNDS DERIVED FROM PIRIDINE 1,4-DISSTITUTED.

Publications (1)

Publication Number Publication Date
ZA943036B true ZA943036B (en) 1995-05-02

Family

ID=8281846

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943036A ZA943036B (en) 1993-05-18 1994-05-03 1,4-disubstituted piperidine derivative compounds

Country Status (12)

Country Link
EP (1) EP0651744A1 (en)
JP (1) JPH07509255A (en)
KR (1) KR950702535A (en)
AU (1) AU675332B2 (en)
CA (1) CA2140260A1 (en)
ES (1) ES2066721B1 (en)
FI (1) FI950197A (en)
NO (1) NO301638B1 (en)
NZ (1) NZ267100A (en)
TW (1) TW252975B (en)
WO (1) WO1994026712A1 (en)
ZA (1) ZA943036B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1999000149A (en) 1998-09-09 2000-01-12 Pfizer Prod Inc DERIVATIVES OF 4,4-BIARILPIPERIDINA

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
SE7409245L (en) * 1973-07-19 1975-01-20 Robins Co Inc A H
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
DK623586A (en) * 1985-12-27 1987-06-28 Eisai Co Ltd PIPERIDE INGREDIENTS OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS
FR2681319B1 (en) * 1991-09-12 1995-02-17 Synthelabo 1- (PHENOXYALKYL) PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
ES2060547B1 (en) * 1992-06-04 1995-06-16 Ferrer Int IMPROVEMENTS IN THE PURPOSE OF THE INVENTION PATENT N / 9201158 THAT REFERS TO "PROCEDURE FOR OBTAINING NEW DERIVATIVES OF 4-BENCILPIPERIDINE".

Also Published As

Publication number Publication date
AU6928494A (en) 1994-12-12
WO1994026712A1 (en) 1994-11-24
TW252975B (en) 1995-08-01
KR950702535A (en) 1995-07-29
ES2066721B1 (en) 1996-02-16
JPH07509255A (en) 1995-10-12
EP0651744A1 (en) 1995-05-10
NO950062D0 (en) 1995-01-06
NO301638B1 (en) 1997-11-24
AU675332B2 (en) 1997-01-30
NO950062L (en) 1995-01-06
FI950197A0 (en) 1995-01-17
FI950197A (en) 1995-01-17
NZ267100A (en) 1996-09-25
ES2066721A1 (en) 1995-03-01
CA2140260A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
HUP9902381A3 (en) Fluorinated 1,4-disubstituted piperidine derivatives
AP9400671A0 (en) Piperidine derivatives
CZ186498A3 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
GB9321855D0 (en) 1,4-piperazine derivatives
EP0714293A4 (en) 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
DE68906801D1 (en) 1,4-DISUBSTITUTED PIPERIDINE COMPOUNDS.
HU9301553D0 (en) 1-(3,4-disubstituted phenyl)-tetrazolinone derivatives
ZA929011B (en) Novel N-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives.
ZA916058B (en) Novel 1,4-dihydropyridine derivatives
HU9602607D0 (en) New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
ZA971735B (en) Novel esters of 1,4-disubstituted piperidine derivatives
AU2793197A (en) 1,4-disubstituted piperidine derivatives
AU8442791A (en) 1,2,5,6-tetrahydropyridine oxime derivatives
IL111016A0 (en) Substituted aminoalkyl-1-(aryloxyalkyl) piperidine compounds
JPS6450863A (en) 1,4-disubstituted 1-azolyl-3,3-dimethylbutane derivative
ZA955438B (en) Polyalkylpiperidine compounds
AU8312191A (en) 1,4-disubstituted piperazines
ZA943036B (en) 1,4-disubstituted piperidine derivative compounds
HU9402436D0 (en) 2,6-method-2h-quinolizin derivative as 5-ht3-receptor antagonist
AU6086998A (en) Process for preparing 1,4-disubstituted piperidine compounds
HRP970094A2 (en) 1,4-dihydropyridine compounds
GB9322017D0 (en) 1,4-piperazine derivatives
ZA976813B (en) Fluorinep-containing 1,4-disubstituted piperidine derivatives.
SG52644A1 (en) Piperidine derivatives